Company / Depreciation & Amortization
Incyte Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$93.3M
FY2025
5-year range
$57.8M / $93.3M
FY2021-FY2025
Trend
+4.5%
vs FY2024
Sector context
#18 of 168
Health Care
What the data says
Incyte's depreciation & amortization of $93M is higher than 89% of companies in the Health Care sector (FY2025). Depreciation & Amortization has increased for 6 consecutive years, from $52M in FY2019 to $93M in FY2025.
Based on SEC 10-K filings.
$93M in FY2025 with a 5-year CAGR of +11.2%. Top quartile in the Health Care sector.
Increased from $83M to $93M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +11.2%
- 5-Year CAGR
- +11.2%
- 10-Year CAGR
- -
Sector benchmark
-56.2% below sector average
Key checks
Key Insights
- Incyte's depreciation & amortization has grown for 6 consecutive years.
- 5-year CAGR of +11.2%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 4.5% year-over-year.
- Ranks #18 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.7%
- Strong return on equity: 25.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $93.3M | +4.5% |
| FY2024 | $89.2M | +8.0% |
| FY2023 | $82.7M | +21.8% |
| FY2022 | $67.9M | +17.3% |
| FY2021 | $57.8M | +5.2% |
| FY2020 | $55.0M | +5.3% |
| FY2019 | $52.2M | -5.1% |
| FY2018 | $55.0M | +5.3% |
| FY2017 | $52.2M | -10.7% |
| FY2016 | $58.4M | +30.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026